• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Contact lens parameters expand to fit a wider range of patients

Article

SynergEyes Inc. expands the parameters of its multifocal hybrid contact lens to address patients with emerging presbyopia seeking binocular visual acuity.

Key Points

SynergEyes Inc. expands the parameters of its multifocal hybrid contact lens to address patients with emerging presbyopia seeking binocular visual acuity.

The lens now is available in a +0.75 D add power in addition to the three add powers (+1.25, +1.75, and +2.25 D) previously offered. The addition of the +0.75 D add will provide a contact lens option for presbyopia.

The multifocal hybrid contact lens combines two materials-a rigid gas permeable center and a soft, hydrophilic outer skirt. The result is a durable hybrid lens that offers high-definition vision, stability and centration, and all-day comfort. The concentric, center-near design of the multifocal lens concentrates optics within two distinct areas of focus: one for distance and one for near to provide simultaneous vision at all points of focus.

Related Videos
William Reindel, OD
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Andrew Pucker, OD, PhD
© 2024 MJH Life Sciences

All rights reserved.